Annovis Bio Inc (ANVS) Business News Dec. 18, 2025, 21:35 UTC Annovis Announces Open-Label Extension Study for Parkinsons Disease Patients Full text
Register to leave comments News bot Dec. 19, 2025, 6:46 a.m. 📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical